PubMed:33012859
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 52-60 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 240-264 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 266-274 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 452-461 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T5 | 1277-1286 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 1491-1499 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 66-73 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T2 | 75-84 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | Objective |
T3 | 137-138 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 176-177 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T5 | 221-228 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T6 | 320-325 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T7 | 345-346 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 419-426 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T9 | 804-809 | http://purl.obolibrary.org/obo/UBERON_0007688 | denotes | field |
T10 | 870-876 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T11 | 1044-1051 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T12 | 1175-1180 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T13 | 1203-1204 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 1245-1246 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T15 | 1392-1397 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T16 | 1414-1421 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T17 | 1505-1512 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T18 | 1670-1675 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T19 | 1695-1696 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 485-490 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T2 | 1212-1217 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 52-60 | Disease | denotes | COVID-19 | MESH:C000657245 |
8 | 240-264 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
9 | 266-274 | Disease | denotes | COVID-19 | MESH:C000657245 |
10 | 452-461 | Disease | denotes | infection | MESH:D007239 |
11 | 756-762 | Species | denotes | people | Tax:9606 |
12 | 1277-1286 | Disease | denotes | infection | MESH:D007239 |
13 | 1491-1499 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-74 | Sentence | denotes | Simulation of pooled-sample analysis strategies for COVID-19 mass testing. |
T2 | 75-85 | Sentence | denotes | Objective: |
T3 | 86-358 | Sentence | denotes | To evaluate two pooled-sample analysis strategies (a routine high-throughput approach and a novel context-sensitive approach) for mass testing during the coronavirus disease 2019 (COVID-19) pandemic, with an emphasis on the number of tests required to screen a population. |
T4 | 359-367 | Sentence | denotes | Methods: |
T5 | 368-497 | Sentence | denotes | We used Monte Carlo simulations to compare the two testing strategies for different infection prevalences and pooled group sizes. |
T6 | 498-633 | Sentence | denotes | With the routine high-throughput approach, heterogeneous sample pools are formed randomly for polymerase chain reaction (PCR) analysis. |
T7 | 634-810 | Sentence | denotes | With the novel context-sensitive approach, PCR analysis is performed on pooled samples from homogeneous groups of similar people that have been purposively formed in the field. |
T8 | 811-925 | Sentence | denotes | In both approaches, all samples contributing to pools that tested positive are subsequently analysed individually. |
T9 | 926-935 | Sentence | denotes | Findings: |
T10 | 936-1087 | Sentence | denotes | Both pooled-sample strategies would save substantial resources compared to individual analysis during surge testing and enhanced epidemic surveillance. |
T11 | 1088-1310 | Sentence | denotes | The context-sensitive approach offers the greatest savings: for instance, 58-89% fewer tests would be required for a pooled group size of 3 to 25 samples in a population of 150 000 with an infection prevalence of 1% or 5%. |
T12 | 1311-1422 | Sentence | denotes | Correspondingly, the routine high-throughput strategy would require 24-80% fewer tests than individual testing. |
T13 | 1423-1434 | Sentence | denotes | Conclusion: |
T14 | 1435-1513 | Sentence | denotes | Pooled-sample PCR screening could save resources during COVID-19 mass testing. |
T15 | 1514-1708 | Sentence | denotes | In particular, the novel context-sensitive approach, which uses pooled samples from homogeneous population groups, could substantially reduce the number of tests required to screen a population. |
T16 | 1709-1873 | Sentence | denotes | Pooled-sample approaches could help countries sustain population screening over extended periods of time and thereby help contain foreseeable second-wave outbreaks. |